NASDAQ (USD): TransMedics Group, Inc. (TMDX)
Last Price
158.79
Today's Change
+14.23 (9.84%)
Day's Change
152.19 - 160.80
Trading Volume
2,071,076
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Investigating SAP, Carahsoft for Potential Price-fixing
2
Brazil Sugar Losses Make Thai and Indian Supply More Important
3
Shippers Scramble for Workarounds Ahead of Threatened US Port Strike
4
Six Weeks Before Election, Trump Vows to Take Other Countries’ Jobs
5
Micron’s Results May Reveal An AI Winner Trading at a Discount
#
Stock
Score
BABA
Alibaba Group Holding Limited
PLTR
Palantir Technologies Inc.
866
CNEY
CN Energy Group. Inc.
666
KTTA
Pasithea Therapeutics Corp.
NVDA
NVIDIA Corporation
566
6
AAPL
Apple Inc.
466
7
MSFT
Microsoft Corporation
400
8
AGN
333
9
ONCO
Onconetix, Inc.
10
SOXL
Direxion Daily Semiconductor Bull 3X Shares
Last
Change
Volume
XPON
0.075
+0.011
243,924,713
0.989
+0.409
215,339,070
120.16
-3.88
214,151,420
TNXP
0.149
+0.012
201,840,192
NIO
6.44
+0.669
159,706,854
SQQQ
7.43
+0.113
121,438,398
LMDX
0.016
-0.018
120,553,903
762.00
-84.71
85,558,284
FXI
32.20
+0.28
83,521,368
DUO
1.24
+0.179
74,457,164
BRK-A
687,527.52
+4,187.50
1,083
NVR
9,745.96
+185.99
7,669
AZO
3,207.75
+18.66
71,609
SMCI
418.81
+16.41
9,556,060
RYSIX
451.17
+15.46
0
TMDX
+14.23
ARGX
538.64
+14.06
91,748
TPL
886.83
+12.93
35,572
CABO
355.93
+11.47
31,755
LULU
280.26
+11.44
2,220,227
MELI
1,629.32
-188.66
1,851,535
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
MPWR
838.63
-96.05
902,546
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
OLED
172.28
-40.39
1,254,445
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....